I agree that this site is using cookies. You can find further informations here.
X
Hendriks, Jenny
135  results:
Search for persons X
?
1

Lot-to-lot consistency, immunogenicity, and safety of the A..:

Goldstein, Neil ; McLean, Chelsea ; Gaddah, Auguste...
Human Vaccines & Immunotherapeutics.  20 (2024)  1 - p. , 2024
Link: https://doi.org/10.1080/..
 
?
2

The Biodistribution of the Spike Protein after Ad26.COV2.S ..:

Marquez-Martinez, Sonia ; Khan, Selina ; Lubbe, Joan van der...
Vaccines.  12 (2024)  5 - p. 559 , 2024
Link: https://doi.org/10.3390/..
 
?
3

Absolute quantitation of binding antibodies from clinical s..:

Tang, Chan ; Verwilligen, Annemiek ; Sadoff, Jerald...
npj Vaccines.  9 (2024)  1 - p. , 2024
Link: https://doi.org/10.1038/..
 
?
4

Persistence of immunological memory as a potential correlat..:

McLean, Chelsea ; Dijkman, Karin ; Gaddah, Auguste...
Frontiers in Immunology.  14 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
5

Immune response of a two-dose heterologous Ebola vaccine re..:

McLean, Chelsea ; Barry, Houreratou ; Kieh, Mark...
eBioMedicine.  91 (2023)  - p. 104562 , 2023
Link: https://doi.org/10.1016/..
 
?
6

Immunogenicity and efficacy of Ad26.COV2.S: An adenoviral v..:

Le Gars, Mathieu ; Hendriks, Jenny ; Sadoff, Jerald...
Immunological Reviews.  310 (2022)  1 - p. 47-60 , 2022
Link: https://doi.org/10.1111/..
 
?
7

Non-human primate to human immunobridging demonstrates a pr..:

Bockstal, Viki ; Leyssen, Maarten ; Heerwegh, Dirk...
npj Vaccines.  7 (2022)  1 - p. , 2022
Link: https://doi.org/10.1038/..
 
?
8

Durable antibody responses elicited by 1 dose of Ad26.COV2...:

Sadoff, Jerald ; Le Gars, Mathieu ; Brandenburg, Boerries...
Vaccine.  40 (2022)  32 - p. 4403-4411 , 2022
Link: https://doi.org/10.1016/..
 
?
9

Impact of Preexisting Anti–Adenovirus 26 Humoral Immunity o..:

Le Gars, Mathieu ; Sadoff, Jerald ; Struyf, Frank...
The Journal of Infectious Diseases.  226 (2022)  6 - p. 979-982 , 2022
Link: https://doi.org/10.1093/..
 
?
10

First-in-human study to evaluate safety, tolerability, and ..:

Bockstal, Viki ; Shukarev, Georgi ; McLean, Chelsea...
PLOS ONE.  17 (2022)  10 - p. e0274906 , 2022
Link: https://doi.org/10.1371/..
 
?
11

SARS-CoV-2 binding and neutralizing antibody levels after A..:

Roozendaal, Ramon ; Solforosi, Laura ; Stieh, Daniel J....
Nature Communications.  12 (2021)  1 - p. , 2021
Link: https://doi.org/10.1038/..
 
?
12

LB7. Ad26.COV2.S-Elicted Neutralizing Activities Against SA..:

Le Gars, Mathieu ; Sadoff, Jerald ; Jongeneelen, Mandy...
Open Forum Infectious Diseases.  8 (2021)  Supplement_1 - p. S804-S805 , 2021
Link: https://doi.org/10.1093/..
 
?
13

The Ratiometric Transcript Signature MX2/GPR183 Is Consiste..:

Du, Ying ; Thompson, Ethan G. ; Muller, Julius...
Frontiers in Immunology.  11 (2020)  - p. , 2020
Link: https://doi.org/10.3389/..
 
?
14

Phase 1 Safety and Immunogenicity Study of a Respiratory Sy..:

Williams, Kristi ; Bastian, Arangassery Rosemary ; Feldman, Robert Allen...
The Journal of Infectious Diseases.  222 (2020)  6 - p. 979-988 , 2020
Link: https://doi.org/10.1093/..
 
?
15

Nonhuman primate to human immunobridging to infer the prote..:

Roozendaal, Ramon ; Hendriks, Jenny ; van Effelterre, Thierry...
npj Vaccines.  5 (2020)  1 - p. , 2020
Link: https://doi.org/10.1038/..
 
1-15